You can purchase shares of ImmunityBio (NASDAQ:IBRX) through any online brokerage.

View our list of the best stock brokerages

Other companies in ImmunityBio’s space includes: Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC), Centessa Pharmaceuticals PLC (NASDAQ:CNTA), Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Xenon Pharmaceuticals Inc (NASDAQ:XENE).

ImmunityBio has a consensus price target of $14.75.

The stock price for ImmunityBio (NASDAQ: IBRX) is $7.74 last updated April 15, 2026 at 7:58 PM EDT.

There are no upcoming dividends for ImmunityBio.

ImmunityBio does not have any upcoming earnings scheduled.

There is no upcoming split for ImmunityBio.

ImmunityBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.